CN Stock MarketDetailed Quotes

300439 Medicalsystem Biotechnology

Watchlist
  • 11.76
  • +0.08+0.68%
Trading Dec 10 11:26 CST
4.52BMarket Cap17.98P/E (TTM)

About Medicalsystem Biotechnology Company

The company is a national high-tech enterprise specializing in R&D, production, sales and service of medical diagnostic products. The company was founded in 2003, stands in Ningbo, on the East China Sea coast, and was successfully listed on the Shenzhen Stock Exchange GEM in 2015. The company is mainly engaged in R&D, production and sales of in vitro diagnostic products, agency business for in vitro diagnostic products, and provides third-party medical diagnostic services. The company's main products are in vitro diagnostic reagents and instruments, third-party medical diagnostic services, and overall smart laboratory solutions. Corporate honors: The company has obtained 455 product registration certificates in China, including 399 in vitro diagnostic reagent product registration certificates and 56 in vitro diagnostic instrument registration certificates; at the same time, the company has obtained a total of 330 overseas registration certifications, including 318 EU CE certifications, 6 Korean KFDA certifications, 3 US FDA certifications, 1 French CNR registration certificate, and 2 Saudi MDMA certifications.

Company Profile

Short Name-A美康生物
Symbol-A300439
Company NameMedicalsystem Biotechnology Co.,Ltd
Listing DateApr 22, 2015
Issue Price27.51
Shares Offered28.34M share(s)
FoundedJul 22, 2003
Legal Representativebingde zou
General Managerjihua zou
Secretaryhuiping xiong
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Securities Representativexiaohan wu
Legal CounselBeijing Guofeng (Hangzhou) Law Firm
Employees1001
Phone0574-88178818
Office AddressNo. 1228, Jinda South Road, Yinzhou District, Ningbo
Zip Code315104
Registered AddressNo. 299, Qiming South Road, Yinzhou District, Ningbo, Zhejiang
Fax0574-88178518
Emailmksw@nbmksw.com
Business License330212000013891
BusinessManufacture and processing of Class II and Class III 6840 in vitro diagnostic reagents; R&D, production and sales of Class I medical devices and precision laboratory instruments; Technology development and research of bioenzymes and reagents; Pharmaceutical biotechnology consulting; Biotechnology promotion, technology development, technology transfer, technical services; maintenance of medical devices; leasing of Class III and II clinical testing analytical instruments; import and export of self-operated or agent goods and technology, except for goods and technologies restricted or prohibited by the country; medical project investment; wholesale and retail of Class II and Class III medical devices; chemical raw materials (except chemical raw materials) Dangerous chemicals and chemicals Sales of drug chemicals) and biochemical agents; information system integration technology transfer, technical consulting services; network technology research and development, consulting, and service; technology research and development, technology transfer, technical consulting, technical service and sales of computer software and hardware; computer sales, installation, and maintenance; health information consulting. (Financial services such as deposit absorption, financing guarantees, valet financial management, and collection (financing) of capital from the public may not be carried out without approval from the financial supervisory authority) (For projects requiring approval according to law, business activities can only be carried out after approval by the relevant department)

Company Executives

  • Name
  • Position
  • Salary
  • bingde zou
  • Chairman, Directors, Chairman of the Strategy Committee, Member of the Remuneration and Assessment Committee, Nomination Committee Members
  • 1.20M
  • jihua zou
  • Directors, General Manager, Strategy Committee Member
  • --
  • gaipeng huang
  • Directors, Audit Committee Member
  • --
  • ling xu
  • Independent Directors, Nomination Committee Members, Chairman of the Remuneration and Assessment Committee, Chairman of the Audit Committee
  • --
  • yunpeng tian
  • Independent Directors, Audit Committee Member, Member of the Remuneration and Assessment Committee, Strategy Committee Member, Chairman of the Nomination Committee
  • 100.00K
  • huiping xiong
  • Board Secretary, Deputy General Manager, Chief Financial Officer
  • --
  • xiaohan wu
  • Securities Affairs Representative
  • --
  • xiaoyan tian
  • Chairman of the Supervisory Board, Auditors
  • 213.00K
  • junqi zhu
  • Auditors
  • 455.90K
  • liang fang
  • Deputy General Manager
  • --
  • min shen
  • Deputy General Manager
  • --
  • jian song
  • Employee Supervisors
  • 299.90K
Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data